By Shanthi Rexaline
Shares of COVID-19 vaccine companies Moderna Inc MRNA 3.82%, Pfizer Inc. PFE 0.44% and BioNTech SE – ADR BNTX 0.75% are moving sharply lower Wednesday.
What Happened: Administering of mRNA vaccines, the class of vaccines developed by Moderna and Pfizer-BioNTech, resulted in higher observed vs. expected myocarditis/pericarditis cases in 16 to 24 years olds following dose two of mRNA vaccines, CDC’s COVID-19 Vaccine Safety Technical Work Group said in a report.
The report was prepared for discussion by CDC’s Advisory Committee on Immunization Practices, which is being held Wednesday to look into a possible link between mRNA vaccines and a heart condition.
Since April, there have been increased reports of cases of inflammation of the heart — myocarditis and pericarditis — after being administered either Pfizer-BioNTech or Moderna’s mRNA vaccines, the panel said in the report.
The Most Revolutionary Act 
Pingback: Moderna, Pfizer Stocks Fall After CDC Panel Flags Heart Inflammation Risk In Young Adults Receiving COVID-19 Vaccine — The Most Revolutionary Act | FREEDOM MINDS FOR THE AMERICAN REPUBLICS
Pingback: HHS cuts funding to ‘undertested’ mRNA technology | Worldtruth